Carbon capture specialist CyanoCapture and liver health firm Ochre Bio are the latest firms to take space in the Hayakawa Building at The Oxford Science Park (TOSP).

And, like the vast majority of the building’s new start-up occupiers, both join from Oxford University’s BioEscalator incubator space.

The 36,000 sq ft building, which includes a clean room, laboratory and office space, is part of TOSP’s portfolio of innovation buildings offering flexible terms for start-up companies. And it now hosts a bespoke chemistry laboratory for Ochre Bio.

TOSP took over management and control of the building from Sharp Laboratories of Europe at the end of last year.

TOSP chief executive Rory Maw said: “CyanoCapture and Ochre Bio are highly complementary to the other innovative companies on the park. We welcome them to the Hayakawa Building, which is also providing valuable space for the expansion of existing occupiers.’

Jack O’Meara, chief executive and co-founder of Ochre Bio, said: “Oxford, through the university, hospitals and local industry, is a world leader in cutting-edge liver disease research and we are delighted to be able to expand our presence here with our new facility at The Oxford Science Park.

“We’re impressed with the team’s speed and efficiency in establishing a high quality laboratory, to enable Ochre to accelerate the development of RNA therapies for chronic liver diseases, a leading cause of death globally.”

© Thames Tap (powered by

Sign up to receive your free weekly Thames Tap journal here.